2 February 2022
Latham & Watkins Advises Astorg, Nordic Capital, and Portfolio Company Clario on Divestiture of Clario’s Drug Safety Solutions to Stanley Capital Partners
Advising firms
Deal team
7 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| David Beller Lead | Latham & Watkins LLP | Partner | M&A | New York |
| Leah Sauter Lead | Latham & Watkins LLP | Partner | M&A | New York |
| Mack Weber | Latham & Watkins LLP | Associate | M&A | Not stated |
| Marc Klepner | Latham & Watkins LLP | Associate | M&A | Not stated |
| Matthew Dewitz | Latham & Watkins LLP | Partner | tax | New York |
| Steven Betensky | Latham & Watkins LLP | Partner | intellectual property | New York |
| Adam Kestenbaum | Latham & Watkins LLP | Partner | benefits and compensation | Washington, D.C. |
4 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- ClarioSell-side
- Counterparties
- Stanley Capital Partners LLP (Buy-side)